About Nautilus Biotechnology
Nautilus Biotechnology focuses on the study of proteins, known as proteomics, to enhance drug development. The company has created a platform that helps researchers gain detailed insights into how drug targets function in relation to health and disease. This platform allows users to identify and prioritize drug targets that are more likely to succeed in clinical trials, which helps to streamline the drug discovery process and lower costs compared to traditional methods. Nautilus Biotechnology primarily serves pharmaceutical companies, research institutions, and biotech firms, providing them with tools to improve their research and clinical outcomes. The company's goal is to unlock the potential of the proteome to drive advancements in biology and medicine, ultimately benefiting global health.